Renin–angiotensin system blockade therapy after transcatheter aortic valve implantation
Heart Jan 17, 2018
Ochiai T, et al. - This study was designed to assess the impact of renin-angiotensin system (RAS) blockade therapy on left ventricular (LV) hypertrophy and mortality in patients undergoing transcatheter aortic valve implantation (TAVI). Findings demonstrated an association of postoperative RAS blockade therapy with greater LV mass index regression and reduced all-cause mortality.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
